Finance

Lists
AQSZF:OTCMKTS
Aequus Pharmaceuticals Inc
0,00030 $
0,00%
(0,00) 1D
14 қаз., 11:50:04 GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for AQSZF...
Avg. vol.
56,71 мың
Volume
0,00
52-wk high
0,01 $
52-wk low
0,00 $
Beta
-2,52
Shares outstanding
132,63 млн
No. of employees
12
Avg. vol.
56,71 мың
Volume
0,00
52-wk high
0,01 $
52-wk low
0,00 $
Beta
-2,52
Shares outstanding
132,63 млн
No. of employees
12
News stories
From web sources and news partners
About Aequus Pharmaceuticals Inc
CEO-
Employees12
Founded2013
HeadquartersВанкувер, Британдық Колумбия, Канада
SectorPharmaceutical industry
Previous reports
Loading Previous Earnings...
Revenue
Net income
All values in CAD
2024 ж. жел.
2025 ж. нау.
2025 ж. мау.
2025 ж. қыр.
Revenue
221,95 м.
226,54 м.
218,22 м.
251,75 м.
Cost of goods sold
74,90 мың
90,09 мың
110,75 м.
119,68 м.
Cost of revenue
74,90 мың
90,09 мың
110,75 м.
119,68 м.
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
454,05 м.
224,01 м.
199,28 м.
219,75 м.
Operating expense
454,05 м.
224,01 м.
199,28 м.
219,75 м.
Total operating expenses
528,95 м.
314,09 м.
310,03 м.
339,43 м.
Operating income
-307,00 м.
-87,55 мың
-91,81 мың
-87,68 мың
Other non operating income
-43,06 мың
-
-
-
EBT including unusual items
-217,81 м.
-645,10 м.
-163,91 м.
370,48 м.
EBT excluding unusual items
-421,46 м.
-159,90 м.
-163,91 м.
-147,62 м.
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-217,81 м.
-645,10 м.
-163,91 м.
370,48 м.
Net profit margin
-98,14%
-284,76%
-75,11%
147,16%
Earnings per share
-
-
-
-
Interest and investment income
2,54 мың
-
-
-
Interest expense
-71,99 мың
-69,97 мың
-70,30 мың
-58,93 мың
Net interest expenses
-69,45 мың
-69,97 мың
-70,30 мың
-58,93 мың
Depreciation and amortization charges
-
-
-
-
EBITDA
-305,55 м.
-
-
-
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
Google қолданбалары